A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity

Oral medications for the treatment of dystonia are not established. Currently, symptoms of focal dystonia are managed with botulinum toxin injections into the affected muscles. However, the injection effects are short-lived and not beneficial for all patients. We recently reported significant clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonyan, Kristina, Frucht, Steven J., Blitzer, Andrew, Sichani, Azadeh Hamzehei, Rumbach, Anna F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208333/
https://www.ncbi.nlm.nih.gov/pubmed/30382161
http://dx.doi.org/10.1038/s41598-018-34553-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208333/
https://www.ncbi.nlm.nih.gov/pubmed/30382161
http://dx.doi.org/10.1038/s41598-018-34553-x

Ejemplares similares